Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Molecular Imaging and Biology
|
December 4, 2019
In vitro and In vivo Assessment of Suitable Reference Region and Kinetic Modelling for the mGluR1 Radioligand [<sup>11</sup>C]ITDM in Mice
Daniele Bertoglio, Jeroen Verhaeghe, Špela Korat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2021
Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 15, 2021
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease
Daniele Bertoglio, Jeroen Verhaeghe, Alan Miranda, et al.
Neuroimage
|
January 26, 2010
D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model
Mette Skinbjerg, Jeih-San Liow, Nicholas Seneca, et al.
Molecular Neurobiology
|
January 9, 2020
Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington's Disease: a Longitudinal PET Study
Daniele Bertoglio, Jeroen Verhaeghe, Špela Korat, et al.
Synapse (New York, N.Y.)
|
June 21, 2008
Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligand
Nicholas Seneca, Mette Skinbjerg, Sami S Zoghbi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 17, 2019
Validation and noninvasive kinetic modeling of [<sup>11</sup>C]UCB-J PET imaging in mice
Daniele Bertoglio, Jeroen Verhaeghe, Alan Miranda, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 24, 2022
Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [<sup>11</sup>C]CHDI-00485180-R and [<sup>11</sup>C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin
Aline Delva, Michel Koole, Kim Serdons, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 17, 2025
PET imaging with [¹¹C]CHDI-00485180-R, designed as radioligand for aggregated mutant huntingtin, in people with Huntington's disease
Aline Delva, Michel Koole, Kim Serdons, et al.
Science Translational Medicine
|
February 2, 2022
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease
Daniele Bertoglio, Jonathan Bard, Manuela Hessmann, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Molecular Imaging and Biology
|
December 4, 2019
In vitro and In vivo Assessment of Suitable Reference Region and Kinetic Modelling for the mGluR1 Radioligand [<sup>11</sup>C]ITDM in Mice
Daniele Bertoglio, Jeroen Verhaeghe, Špela Korat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2021
Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 15, 2021
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease
Daniele Bertoglio, Jeroen Verhaeghe, Alan Miranda, et al.
Neuroimage
|
January 26, 2010
D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model
Mette Skinbjerg, Jeih-San Liow, Nicholas Seneca, et al.
Molecular Neurobiology
|
January 9, 2020
Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington's Disease: a Longitudinal PET Study
Daniele Bertoglio, Jeroen Verhaeghe, Špela Korat, et al.
Synapse (New York, N.Y.)
|
June 21, 2008
Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligand
Nicholas Seneca, Mette Skinbjerg, Sami S Zoghbi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 17, 2019
Validation and noninvasive kinetic modeling of [<sup>11</sup>C]UCB-J PET imaging in mice
Daniele Bertoglio, Jeroen Verhaeghe, Alan Miranda, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 24, 2022
Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [<sup>11</sup>C]CHDI-00485180-R and [<sup>11</sup>C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin
Aline Delva, Michel Koole, Kim Serdons, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 17, 2025
PET imaging with [¹¹C]CHDI-00485180-R, designed as radioligand for aggregated mutant huntingtin, in people with Huntington's disease
Aline Delva, Michel Koole, Kim Serdons, et al.
Science Translational Medicine
|
February 2, 2022
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease
Daniele Bertoglio, Jonathan Bard, Manuela Hessmann, et al.
Page
of 2